Search
A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.
Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution as President and Chief Executive Officer.
MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.
A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.
Discover how MSK Kids is using medical play to help children understand treatments and procedures.
Learn about George Bosl, who will become MSK's first ombudsperson.
Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
New MSK research illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA sequencing to shed new light on the evolution of pancreatic cancer.